Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ARTL
ARTELO BIOSCIENCES, INC.
NASDAQ
$0.66
▲ UP 0.26% (0.00)

KEY STATISTICS

Market Cap$2.31 M
52w High$27.75
52w Low$0.52
Dividend Yield—
Frequency—
P/E-0.03
Volume2.27M
Shares Out.3.49M

COMPANY

LEADERSHIP

Gregory D. Gorgas
CHIEF EXECUTIVE
Gregory D. Gorgas

COMPENSATION 2026

Salary$540,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$66,923
Total$1,223,455

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 21, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.—
NOV
17
TUE

SPLIT RECORD

DATETYPERATIO
2026-03-10Reverse1:3
2025-06-13Reverse1:6
2022-08-10Reverse1:15
2019-06-21Reverse1:8

PRICE

$0.66 ▲ UP 0.26% (+$0.00)
OVERLAYS
$0.62$0.64$0.66$0.689:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.66

About Artelo Biosciences, Inc.

https://www.artelobio.com ↗

Artelo Biosciences, Inc. is a clinical-stage biopharma developing endocannabinoid system therapies, including ART27.13 for cancer-related anorexia, ART12.11 for inflammatory and PTSD conditions, and ART26.12 for cancer and PTSD, with research coll...

INDUSTRY

Biotechnology

A PRODUCT ARTELO BIOSCIENCES, INC. IS KNOWN FOR

ART27.13
ART27.13

ART27.13, Artelo's lead Phase 2 clinical-stage synthetic cannabinoid, is developed to treat cancer-related anorexia and weight loss, addressing an unmet medical need with no current FDA-approved options.

COMPETITORS

COMPETITOR
ABBV COMPARE
CRBP COMPARE
JAZZ COMPARE
TLRY COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 10.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.43%
HOLDERS
1
TOP 1 OF 1 · RANKED BY POSITION SIZE
Keystone Wealth Partners
15.0K sh · $7K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score2

INSIDER TRADES

★
DIRECTOR
Blayney Douglas
Purchase · 136 shares
2026-07-17
★
DIRECTOR
Kelly Steven
Purchase · 136 shares
2026-07-17
★
DIRECTOR
FAVORITO TAMARA A
Purchase · 136 shares
2026-07-17
★
DIRECTOR
MATSUI CONNIE
Purchase · 136 shares
2026-07-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 2
2 GRADES IN THE LAST 12 MONTHS
Maxim Group HOLD D. Boral Capital HOLD

SECTORS PEERS

PEERPRICE
GTBP$0.30COMPARE
REVB$1.05COMPARE
PTIX$0.98COMPARE
SPRC$6.58COMPARE
SLXN$0.36COMPARE
PBM$4.21COMPARE
CARM$0.00COMPARE
WINT$0.00COMPARE